Insider purchase
Richard MacPherson, President and CEO of Birchtech Corp (NASDAQ:BCHT), reported purchasing 312,500 shares of the company's common stock at $2.40 per share. The transaction, with a reported value of $750,000, took place on February 27, 2026.
Share price context
At the time of the report, BCHT shares were trading at $2.36, trading close to their 52-week low of $2.00 and following a sharp 16% decline over the prior week. An InvestingPro tip noted that the stock's relative strength index, or RSI, indicates it is in oversold territory; subscribers have access to 11 additional ProTips and comprehensive financial metrics related to insider transactions.
Financing move
Separately, Birchtech announced the pricing of an underwritten public offering consisting of 6,250,000 shares of common stock at $2.40 per share. The offering is expected to generate gross proceeds of approximately $15 million, before taking into account underwriting discounts and other offering-related expenses. The company stated it intends to use net proceeds to support ongoing operating expenses, working capital needs, and general corporate purposes.
Legal enforcement
On the legal front, Birchtech has taken steps to secure payment of a $78 million judgment against CERT entities. That judgment was entered by the U.S. District Court of Delaware after a jury trial found CERT liable for willful infringement, including inducing and contributory infringement. The company’s request for payment followed the expiration of a 30-day stay of execution.
What this collection of moves represents
Taken together, the insider purchase, the underwritten offering, and the effort to collect on a substantial court judgment reflect concurrent corporate-finance and legal developments at Birchtech. The disclosed insider buy and the pricing of a capital raise occurred at the same $2.40 per-share level referenced in the offering pricing, while market indicators noted by third-party tools signal recent downward momentum in the share price.
Key points
- CEO Richard MacPherson purchased 312,500 shares at $2.40 on February 27, 2026, for $750,000.
- Birchtech priced an underwritten offering of 6,250,000 shares at $2.40 per share, expected to generate roughly $15 million in gross proceeds before fees.
- The company is pursuing payment of a $78 million judgment against CERT entities after a jury verdict in the U.S. District Court of Delaware and the expiration of a 30-day stay of execution.
Risks and uncertainties
- Market risk: BCHT shares have recently declined and are trading near their 52-week low, reflecting short-term downward pressure in the market.
- Dilution risk: The underwritten public offering will increase the number of outstanding shares and could dilute existing holders once the offering is completed.
- Collection and timing risk: While Birchtech has sought payment of a $78 million judgment following the expiration of a 30-day stay, the timing and mechanics of actual collection are not detailed in the company's disclosures.
Sectors impacted
- Healthcare and biotech - as the company operates within this sector and legal and financing developments may affect its operational runway.
- Capital markets - the underwritten offering and insider activity are directly relevant to equity investors and market liquidity for BCHT.
- Legal/Intellectual property enforcement - the judgment and post-trial collection efforts have implications for litigation outcomes and monetization.